Opposing roles of STAT1 and STAT3 in IL-21 function in CD4⁺ T cells
IL-21 is a type I cytokine essential for immune cell differentiation and function. Although IL-21 can activate several STAT family transcription factors, previous studies focused mainly on the role of STAT3 in IL-21 signaling. Here, we investigated the role of STAT1 and show that STAT1 and STAT3 hav...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 112; no. 30; pp. 9394 - 9399 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
28.07.2015
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | IL-21 is a type I cytokine essential for immune cell differentiation and function. Although IL-21 can activate several STAT family transcription factors, previous studies focused mainly on the role of STAT3 in IL-21 signaling. Here, we investigated the role of STAT1 and show that STAT1 and STAT3 have at least partially opposing roles in IL-21 signaling in CD4⁺ T cells. IL-21 induced STAT1 phosphorylation, and this was augmented inStat3-deficient CD4⁺ T cells. RNA-Seq analysis of CD4⁺ T cells fromStat1-andStat3-deficient mice revealed that both STAT1 and STAT3 are critical for IL-21–mediated gene regulation. Expression of some genes, includingTbx21andIfng, was differentially regulated by STAT1 and STAT3. Moreover, opposing actions of STAT1 and STAT3 on IFN-γexpression in CD4⁺ T cells were demonstrated in vivo during chronic lymphocytic choriomeningitis infection. Finally, IL-21–mediated induction of STAT1 phosphorylation, as well asIFNGandTBX21expression, were higher in CD4⁺ T cells from patients with autosomal dominant hyper-IgE syndrome, which is caused by STAT3 deficiency, as well as in cells from STAT1 gain-of-function patients. These data indicate an interplay between STAT1 and STAT3 in fine-tuning IL-21 actions. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 2Present address: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115. Author contributions: C.-K.W., A.B.A., P.L., and W.J.L. designed research; C.-K.W., A.B.A., R.S., P.L., M.K., J.O., L.S., P.A.S., E.P.S., and A.F.F. performed research; C.-K.W., A.B.A., R.S., P.L., M.K., D.B.M., and W.J.L. analyzed data; and C.-K.W., A.B.A., P.L., D.B.M., J.D.M., S.M.H., and W.J.L. wrote the paper. Reviewers: T.R.M., Miller School of Medicine, University of Miami; and H.A.Y., National Cancer Institute. Contributed by Warren J. Leonard, June 18, 2015 (sent for review May 19, 2015; reviewed by Thomas R. Malek and Howard A. Young) 1C.-K.W., and A.B.A. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1511711112 |